GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Jan 8, 2015 · 10-K · 373 days after period end · 0001513160-15-000005
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $220.00K | $3.00K | — |
| Net Income | -$331.00K | -$761.00K | -$1.14M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Jan 8, 2015 · 373 d after period end
